| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 1,4 M € | +13.3% | 1,2 M € | +2.0% | 1,2 M € | +29.9% | 930,2 k € | +79.6% | 517,8 k € | +36.5% | 379,2 k € | +16.4% | 325,9 k € | +19.2% | 273,3 k € | +150.0% | 109,3 k € | +219.7% | 34,2 k € | |
| EBITDA | 1,0 M € | +8.6% | 947,7 k € | -2.7% | 973,5 k € | +12.9% | 862,1 k € | +73.1% | 498,1 k € | +31.4% | 379,2 k € | +16.4% | 325,9 k € | +19.2% | 273,3 k € | +150.0% | 109,3 k € | +219.7% | 34,2 k € | |
| Operating profit | 818,9 k € | -13.2% | 943,3 k € | -2.8% | 970,8 k € | +14.6% | 847,2 k € | +75.2% | 483,5 k € | +32.6% | 364,6 k € | +146.8% | 147,7 k € | -42.9% | 258,7 k € | +136.6% | 109,3 k € | +219.7% | 34,2 k € | |
| Profit/loss | 983,2 k € | +53.2% | 642,0 k € | -63.4% | 1,8 M € | +112.8% | 825,1 k € | +19.3% | 691,5 k € | +69.8% | 407,3 k € | -67.8% | 1,3 M € | +1787.2% | 67,1 k € | +60.9% | 41,7 k € | +166.0% | 15,7 k € | |
| Equity | 6,8 M € | +16.8% | 5,9 M € | +12.3% | 5,2 M € | +50.7% | 3,5 M € | +31.3% | 2,6 M € | +35.5% | 1,9 M € | +26.4% | 1,5 M € | +461.3% | 274,5 k € | +32.4% | 207,4 k € | +25.2% | 165,7 k € | |
| Total assets | 16,7 M € | +6.9% | 15,6 M € | +8.5% | 14,4 M € | +3.0% | 14,0 M € | +46.0% | 9,6 M € | +18.0% | 8,1 M € | +7.5% | 7,5 M € | +21.2% | 6,2 M € | +28.5% | 4,8 M € | +432.3% | 910,1 k € | |
| Cash | 462,4 k € | +116.8% | 213,3 k € | -46.8% | 401,3 k € | +40.5% | 285,6 k € | +187.0% | 99,5 k € | -77.8% | 449,2 k € | +872.0% | 46,2 k € | +82.2% | 25,4 k € | +476.2% | 4,4 k € | +1.6% | 4,3 k € | |
| Debts | 9,6 M € | -1.2% | 9,8 M € | +6.3% | 9,2 M € | -12.7% | 10,5 M € | +51.6% | 6,9 M € | +12.4% | 6,2 M € | +2.7% | 6,0 M € | +0.9% | 6,0 M € | +28.4% | 4,6 M € | +522.9% | 744,4 k € | |
| Staff | 6,7 | 6 | 4,9 | 1,3 | 0,5 | — | — | — | — | — | ||||||||||
Private limited company · Seneffe · incorporated on 16/12/2014 · 6,7 ETP
Private limited company profitable and well capitalised. Cash position rising (+116.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DEVANTHINIC PHARMA is a Private limited company incorporated in 2014. Its main activity is: Activities of holding companies. Its registered office is in Seneffe. It employs on average 6,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette